fingolimod hydrochloride has been researched along with Autoimmune Diseases of the Nervous System in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balboni, A; Borghi, A; Camilli, F; Di Felice, G; Giannoccaro, MP; Lazzarotto, T; Leone, M; Liguori, R; Lodi, V; Lugaresi, A; Panzera, I; Rinaldi, R; Salvi, F; Tappatà , M; Vacchiano, V; Zenesini, C | 1 |
1 other study(ies) available for fingolimod hydrochloride and Autoimmune Diseases of the Nervous System
| Article | Year |
|---|---|
Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study.
Topics: 2019-nCoV Vaccine mRNA-1273; Adult; Aged; Antibodies, Viral; Autoimmune Diseases of the Nervous System; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Fingolimod Hydrochloride; Humans; Immunity, Humoral; Immunoglobulin G; Longitudinal Studies; Middle Aged; SARS-CoV-2 | 2022 |